Teva recalls ketamine injections
The recall, issued Dec. 21, affects USP CIII 100 mg/mL in 10 mL vials for all lot numbers within their expiration dates at the veterinary level, FDA says. The injection has previously been recalled at the distributor level. The recall expanded because of "an increased trend in serious adverse events associated with this product," FDA reports in a prepared statement.
Veterinarians should stop using the recalled ketamine injectable immediately and return all existing products to the distributor, FDA says.
At presstime, Teva Animal Health did not return telephone calls seeking comment.
Veterinarians can direct questions about the recall to Teva at (800) 759-3664 between the hours of 8 a.m. and 5 p.m. CST.